Skip to main content

Month: April 2025

Vallourec in Exclusive Negotiations to Sell Serimax, Its Subsidiary Specializing in Welding Solutions, for €79 Million

VALLOUREC IN EXCLUSIVE NEGOTIATIONS TO SELL SERIMAX, ITS SUBSIDIARY SPECIALIZING IN WELDING SOLUTIONS, FOR €79 MILLION Meudon (France), April 14th, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces today that it has entered into exclusive negotiations with Aldebaran, a French investment company, for the sale of Serimax, Vallourec’s subsidiary specializing in mechanized welding solutions, for an enterprise value of €79 million, of which €7 million will be paid via an earn-out. The completion of the sale is expected in the next few months, subject to consultation of the employee representative bodies and satisfaction of customary conditions precedent, including obtaining the necessary regulatory approvals. This transaction is part of the New Vallourec’s initiatives to rationalize its invested capital and...

Continue reading

BNP Paribas SA: ACQUISITION BY BNP PARIBAS CARDIF OF AXA INVESTMENT MANAGERS – UPDATE

ACQUISITION BY BNP PARIBAS CARDIF OF AXA INVESTMENT MANAGERS – UPDATE PRESS RELEASE Paris, 14 April 2025 After entering into exclusive negotiations on 1 August 2024, AXA and BNP Paribas Cardif signed a Share Purchase Agreement for AXA Investment Managers (AXA IM). The closing is expected in early July 2025. In this context, the BNP Paribas Group fully confirms the strategic and industrial interest of the transaction to build a leading platform in asset management that will allow the Group to become the forefront European player in the management of long-term savings assets for insurers and pension funds. This platform will benefit from AXA IM’s leading market position and its team’s expertise specialised in private assets, which will drive further growth with both institutional and retail investors. This acquisition aligns perfectly with...

Continue reading

European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy

Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy1,2 DLBCL is an aggressive cancer with a high risk of progression meaning urgent and effective treatments are needed for people who relapse or have refractory disease This Columvi regimen offers a much needed off-the-shelf and fixed-duration treatment option for those ineligible for transplantBasel, 14 April 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) not otherwise specified who are ineligible for autologous stem...

Continue reading

Fortescue and CMB.TECH sign agreement for ammonia-powered ore carrier

Antwerp, April 14, 2025 (GLOBE NEWSWIRE) — CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) has signed an agreement with Fortescue to charter a new ammonia-powered vessel.  This emphasises the commitment of both companies to decarbonise the shipping industry. This 210,000-dwt ammonia-powered Newcastlemax will feature a dual fuel engine and is expected to be delivered by the end of 2026. Fortescue and Bocimar, part of CMB.TECH, have signed an agreement for an ammonia-powered Newcastlemax featuring a dual fuel engine. The 210,000-dwt vessel is part of CMB.TECH’s series of large dry bulk carriers currently on order at Qingdao Beihai Shipyard and is expected to be delivered to Fortescue by the end of next year. It will play a vital role taking iron ore from the Pilbara to customers in China and around the...

Continue reading

Hepsor and EfTEN are jointly developing nearly 300 apartments in Lasnamäe

Hepsor AS is starting a collaboration with the EfTEN Special Opportunities Fund, a trust fund managed by EfTEN Capital, to start a joint development project in Lasnamäe. Hepsor AS’s subsidiary, Hepsor Finance OÜ, signed a shareholder agreement under which a 50% stake in Hepsor SOF OÜ was sold to the EfTEN Special Opportunities Fund, managed by EfTEN Capital. The sale of the stake in Hepsor SOF OÜ forms the basis for the joint implementation of the development project located in Lasnamäe. On April 10, 2025, a shareholders’ agreement was signed for Hepsor SOF OÜ, under which Hepsor SOF OÜ will acquire the following properties from companies within the Hepsor Group for a total price of 9.0 million euros (plus VAT): A real rights agreement was concluded between Hepsor Fortuuna OÜ and Hepsor SOF OÜ, under which properties located at Paevälja...

Continue reading

Liberty Gold Provides Update on Spin-Out of Goldstrike/Antimony Ridge Project, Southwest Utah into Specialty American Metals Inc.

VANCOUVER, British Columbia, April 13, 2025 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is pleased to provide an update on the “spin-out” process to shareholders of its wholly-owned subsidiary that holds the Goldstrike Project with the Antimony Ridge discovery which is expected to be renamed Specialty American Metals Inc. (“Specialty American”), currently owned 100% by Liberty Gold. HighlightsSpecialty American is expected to hold the Goldstrike Project and its recent Antimony Ridge discovery. The proposed spinout structure is expected to be effected by a plan of arrangement (the “Arrangement”) between Liberty Gold and Specialty American and is expected to be subject to customary conditions, including shareholder, regulatory and court approval. Under the Arrangement, a portion...

Continue reading

Norwegian Cruise Line Holdings Announces Development Plans for Private Island Destination, Great Stirrup Cay

Infrastructure Enhancements to Elevate Guest Experience and Support Multi-Ship Pier Beginning in Fourth Quarter 2025 MIAMI, April 13, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) today announced plans to build out new amenities and enhancements at Great Stirrup Cay, its private island destination in the Bahamas. The upgrades are scheduled to debut in the fourth quarter of 2025 alongside the completion of a new multi-ship pier. The enhancements include the addition of a new welcome center; a new extensive pool area with swim-up bar, family splash pad and poolside cabanas, and an island-wide tram system designed to support seamless exploration of the island. Several onboard premium concepts featured in Norwegian Cruise Line ships will also come to the island, including the adults-only Vibe Beach Club and...

Continue reading

Cygnus Metals Limited: Cleansing Notice

TORONTO, April 13, 2025 (GLOBE NEWSWIRE) — Further to its ASX announcement on 2 April 2025, Cygnus Metals Limited (“Cygnus” or the “Company”) advises that it has issued a total of 300,000 fully paid ordinary shares (“Shares”) to Stria Lithium Inc. as consideration for a two-year extension to the earn-in for the Pontax Lithium Project. Cygnus confirms that the Shares are subject to a 4-month (not 12-month) voluntary holding lock. Cygnus issued the Shares without disclosure under section 708A(5) of the Corporations Act 2001 (Cth) (“Act”). With reference to those Shares issued, in accordance with section 708A(6) of the Act, the Company gives notice under paragraph 708A(5)(e) that:the Company issued the Shares without disclosure under Part 6D.2 of the Act; and as at the date of this notice: a) the Company has complied with the provisions...

Continue reading

IDEX Biometrics ASA: Mandatory notification of trades

IDEX Biometrics ASA informs of primary insider transactions as listed in the attached notifications. For further information contact: Marianne Bøe, Head of Investor Relations, Tel: +47 91800186 Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@idexbiometrics.com This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and Section 5-12 of the Norwegian Securities Trading Act.Attachments2025-04-11 Morten Opstad Chairman Primary Insider2025-04-11 Anders Storbraten CEO Primary Insider

Continue reading

Kane Biotech Announces New Agreement with Outside the Box Capital Inc.

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech” or the “Company”) announces today that it has terminated the previously announced service agreement dated January 17, 2025 (the “Previous OTBC Service Agreement”) with independent marketing firm Outside the Box Capital Inc. (“OTBC”) and entered into a new service agreement dated April 11, 2025 (the “New OTBC Service Agreement”) with OTBC to provide marketing services to communicate information about Kane to the financial community. These marketing services include digital marketing through various social media channels to broaden media distribution awareness about the Company. Pursuant to the terms of the Previous OTBC Service Agreement,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.